# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-008312
Filing Date
2020-05-22
Accepted
2020-05-22 17:13:17
Documents
58
Period of Report
2020-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cpix-20200331.htm iXBRL | 10-Q | 1149352
2 | EX-31.1 | a2020q1-exhibit311.htm | EX-31.1 | 16755
3 | EX-31.2 | a2020q1-exhibit312.htm | EX-31.2 | 16764
4 | EX-32.1 | a2020q1-exhibit321.htm | EX-32.1 | 9386
| Complete submission text file | 0001628280-20-008312.txt |  | 4600499

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20200331.xsd | EX-101.SCH | 32606
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cpix-20200331_cal.xml | EX-101.CAL | 73447
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cpix-20200331_def.xml | EX-101.DEF | 124482
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20200331_lab.xml | EX-101.LAB | 396168
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20200331_pre.xml | EX-101.PRE | 254006
17 | EXTRACTED XBRL INSTANCE DOCUMENT | cpix-20200331_htm.xml | XML | 665661

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 20907011
SIC: 2834 Pharmaceutical Preparations